Evidence map›Paper›PMID 32937026›Full record

ArticleArthritis care & research2022

Significant Gains in Rheumatoid Arthritis Quality Measures Among RISE Registry Practices.

Zara Izadi, Gabriela Schmajuk, Milena Gianfrancesco, Meera Subash, Michael Evans, Laura Trupin, Jinoos Yazdany

Open access · greenAbstract read
In one paragraph

Article in Arthritis care & research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Zara IzadiUniversity of California, San Francisco.ORCID 0000-0002-1867-0905
Gabriela SchmajukSan Francisco Veterans Affairs Medical Center and University of California, San Francisco.ORCID 0000-0003-2687-5043
Milena GianfrancescoUniversity of California, San Francisco.ORCID 0000-0002-8351-4626
Meera SubashUniversity of California, San Francisco.
Michael EvansUniversity of California, San Francisco.
Laura TrupinUniversity of California, San Francisco.
Jinoos YazdanyUniversity of California, San Francisco.ORCID 0000-0002-3508-4094
University of California, San Francisco · USSan Francisco VA Medical Center · US

Funding

RESOURCE-BASED CENTER FOR THE ADVANCEMENT OF PRECISION MEDICINE IN RHEUMATOLOGYP30AR070155 · NIAMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Mary C Nakamura · 2016 to 2026
$8.2M
Advancing Quality and Outcomes Measurement in RheumatologyK24AR074534 · NIAMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Jinoos Yazdany · 2019 to 2026
$1.5M
Rheumatology Informatics System for Effectiveness Patient-Reported Outcome (RISE-PRO) Dissemination ProjectR18HS025638 · AHRQ · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI YAZDANY, JINOOS · 2018 to 2020
$1.5M
ASPIRE: Advancing Safety Process Innovation in RheumatologyR01HS024412 · AHRQ · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI YAZDANY, JINOOS · 2015 to 2017
$1.4M
Computational methods using electronic health records and registry data to detect and predict clinical outcomes in rheumatic diseaseK01AR075085 · NIAMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GIANFRANCESCO, MILENA ANNE · 2019 to 2022
$458k
Agency for Healthcare Research and Quality R01-HS-024412Agency for Healthcare Research and Quality R18-HS-025638AHRQ HHS R01 HS024412AHRQ HHS R18 HS025638American College of RheumatologyNIAMS NIH HHS K01 AR075085NIAMS NIH HHS K24 AR074534NIAMS NIH HHS K24-AR-074534NIAMS NIH HHS P30 AR070155NIAMS NIH HHS P30-AR-070155Russell/Engleman Medical Research Center for Arthritis
6 · The paper itself

Abstract

objectiveUsing the American College of Rheumatology Rheumatology Informatics System for Effectiveness (RISE) registry, our objective was to examine performance on rheumatoid arthritis (RA) quality measures and to assess the association between practice characteristics and changes in performance over time among participating practices.

methodsWe analyzed data from practices enrolled in RISE between January 1, 2015 and December 31, 2017. Eight quality measures in the areas of RA disease management, cardiovascular risk reduction, and patient safety were examined. Variability in performance was evaluated at the practice level. Multivariate linear models were used to predict change in measure performance by year and to determine the effect of practice characteristics on change in performance over time.

resultsData from 59,986 patients from 54 practices were examined. The mean ± SD age was 62 ± 14 years, 77% were female, 69% were Caucasian, and most patients were seen in a single-specialty group practice (46%). The average performance on measures related to RA treatments was consistently high (>90%) across the study period. Measures related to RA functional status and disease activity assessment had the greatest improvements over time (8.4% and 13.0% increase per year, respectively; P < 0.001). Single-specialty group practices had the fastest rates of improvement over time across all measures.

conclusionAmong practices participating in RISE between 2015 and 2017, performance on most RA quality measures improved. Single-specialty group practices saw the fastest rates of improvement over time. Identification of workflow patterns leading to dramatic improvements in quality of care will help guide process redesign to address gaps in priority areas, such as tuberculosis screening and blood pressure control.

Indexed as

RegistriesAgedArthritis, RheumatoidFemaleHumansMaleMiddle AgedQuality Indicators, Health CareRheumatology

Identifiers

PMID32937026
PMCPMC7960552
OpenAlexW3087372790

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.